EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM

Virology

Volumn 385, Issue 1, 2009, Pages 261-266

  Hsiao, Francis C ^a   Tai, Albert K ^a   Deglon, Agnes ^a   Sutkowski, Natalie ^a   Longnecker, Richard ^b   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

EBV; HERV; ITAM; LMP 2A; Superantigen; Transcription

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; LATENT MEMBRANE PROTEIN 2; SUPERANTIGEN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; B LYMPHOCYTE; ELECTROPORATION; EPSTEIN BARR VIRUS; GENE SEQUENCE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN MOTIF; RETROVIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION;

AMINO ACID MOTIFS; ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; ENDOGENOUS RETROVIRUSES; HERPESVIRUS 4, HUMAN; INTERLEUKIN-2; MEMBRANE PROTEINS; MICE; MUTATION; SUPERANTIGENS; TRANSCRIPTIONAL ACTIVATION; VIRAL MATRIX PROTEINS; VIRUS ACTIVATION;

HUMAN ENDOGENOUS RETROVIRUS; HUMAN HERPESVIRUS 4; MURINAE;

EID: 60349094880     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.11.025     Document Type: Article

References (35)

1. Bannert N., and Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U. S. A. 101 Suppl 2 (2004) 14572-14579
2. Barbulescu M., Turner G., Seaman M.I., Deinard A.S., Kidd K.K., and Lenz J. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr. Biol. 9 16 (1999) 861-868
3. Beaufils P., Choquet D., Mamoun R.Z., and Malissen B. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO. J. 12 13 (1993) 5105-5112
4. Burg D.L., Furlong M.T., Harrison M.L., and Geahlen R.L. Interactions of Lyn with the antigen receptor during B cell activation. J. Biol. Chem. 269 45 (1994) 28136-28142
5. Burkhardt A.L., Brunswick M., Bolen J.B., and Mond J.J. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc. Natl. Acad. Sci. U. S. A. 88 16 (1991) 7410-7414
6. Cambier J.C. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL). Immunol. Today 16 2 (1995) 110
7. Casau A.E., Vaughan J.E., Lozano G., and Levine A.J. Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice. J. Virol. 73 12 (1999) 9976-9983
8. Domansky A.N., Kopantzev E.P., Snezhkov E.V., Lebedev Y.B., Leib-Mosch C., and Sverdlov E.D. Solitary HERV-K LTRs possess bi-directional promoter activity and contain a negative regulatory element in the U5 region. FEBS Lett. 472 2-3 (2000) 191-195
9. Fruehling S., and Longnecker R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235 2 (1997) 241-251
10. Fruehling S., Swart R., Dolwick K.M., Kremmer E., and Longnecker R. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72 10 (1998) 7796-7806
11. Gergely J., Pecht I., and Sarmay G. Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells. Immunol. Lett. 68 1 (1999) 3-15
12. Hasuike S., Miura K., Miyoshi O., Miyamoto T., Niikawa N., Jinno Y., and Ishikawa M. Isolation and localization of an IDDMK1,2-22-related human endogenous retroviral gene, and identification of a CA repeat marker at its locus. J. Hum. Genet. 44 5 (1999) 343-347
13. Hsiao F.C., Lin M., Tai A., Chen G., and Huber B.T. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J. Immunol. 177 4 (2006) 2056-2060
14. Isakov N. ITAMs: immunoregulatory scaffolds that link immunoreceptors to their intracellular signaling pathways. Recept. Channels 5 5 (1998) 243-253
15. Justement L.B., Kreiger J., and Cambier J.C. Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig. J. Immunol. 143 3 (1989) 881-889
16. Klaman L.D., and Thorley-Lawson D.A. Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site. J. Virol. 69 2 (1995) 871-881
17. Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Annu. Rev. Immunol. 17 (1999) 555-592
18. Kurosaki T., Johnson S.A., Pao L., Sada K., Yamamura H., and Cambier J.C. Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J. Exp. Med. 182 6 (1995) 1815-1823
19. Leupin O., Attanasio C., Marguerat S., Tapernoux M., Antonarakis S.E., and Conrad B. Transcriptional activation by bidirectional RNA polymerase II elongation over a silent promoter. EMBO Rep. 6 10 (2005) 956-960
20. Longnecker R., Druker B., Roberts T.M., and Kieff E. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65 7 (1991) 3681-3692
21. Lu J., Lin W.H., Chen S.Y., Longnecker R., Tsai S.C., Chen C.L., and Tsai C.H. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J. Biol. Chem. 281 13 (2006) 8806-8814
22. Marrack P., and Kappler J. The staphylococcal enterotoxins and their relatives. Science 248 4959 (1990) 1066
23. Matskova L., Ernberg I., Pawson T., and Winberg G. C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal. J. Virol. 75 22 (2001) 10941-10949
24. Monroe J.G. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat. Rev. Immunol. 6 4 (2006) 283-294
25. Nelson P.N., Carnegie P.R., Martin J., Davari Ejtehadi H., Hooley P., Roden D., Rowland-Jones S., Warren P., Astley J., and Murray P.G. Demystified. Human endogenous retroviruses. Mol. Pathol. 56 1 (2003) 11-18
26. Rolli V., Gallwitz M., Wossning T., Flemming A., Schamel W.W., Zurn C., and Reth M. Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop. Mol. Cell 10 5 (2002) 1057-1069
27. Sjottem E., Anderssen S., and Johansen T. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3′ to the TATA box. J. Virol. 70 1 (1996) 188-198
28. Stauffer Y., Marguerat S., Meylan F., Ucla C., Sutkowski N., Huber B., Pelet T., and Conrad B. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity 15 4 (2001) 591-601
29. Sutkowski N., Conrad B., Thorley-Lawson D.A., and Huber B.T. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15 4 (2001) 579-589
30. Sutkowski N., Chen G., Calderon G., and Huber B.T. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the HERV-K18 superantigen. J. Virol. 78 (2004) 7852-7860
31. Swart R., Fruehling S., and Longnecker R. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction. Virology 263 2 (1999) 485-495
32. Tonjes R.R., Czauderna F., and Kurth R. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J. Virol. 73 11 (1999) 9187-9195
33. Turner G., Barbulescu M., Su M., Jensen-Seaman M.I., Kidd K.K., and Lenz J. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11 19 (2001) 1531-1535
34. Vinogradova T.V., Leppik L.P., Nikolaev L.G., Akopov S.B., Kleiman A.M., Senyuta N.B., and Sverdlov E.D. Solitary human endogenous retroviruses-K LTRs retain transcriptional activity in vivo, the mode of which is different in different cell types. Virology 290 1 (2001) 83-90
35. Yokozeki T., Adler K., Lankar D., and Bonnerot C. B cell receptor-mediated Syk-independent activation of phosphatidylinositol 3-kinase, Ras, and mitogen-activated protein kinase pathways. J. Immunol. 171 3 (2003) 1328-1335